Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PHENOTYPIC CHARACTERIZATION OF TWO NOVEL CELL LINE MODELS OF CASTRATION RESISTANT PROSTATE CANCER

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.04.450352Source: DataRank Database

PHENOTYPIC CHARACTERIZATION OF TWO NOVEL CELL LINE MODELS OF CASTRATION RESISTANT PROSTATE CANCER is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (30)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Akshay Bhamidipati ORCID,Harrison Tsai ORCID,David Esopi,Ajay Vaghasia ORCID,Jin‐Yih Low ORCID

Live enrichment

PubMed:26207759 OpenAlex:https://openalex.org/W3182282079

National Institutes of Health

Grant: 3P50CA058236-02S1

SPECIALIZED PGM OF RESEARCH EXCELLENCE/PROSTATE CANCER

Swiss National Science Foundation

Grant: 166435

MitoModules: Biomarkers in context

National Institutes of Health

Grant: 3P30CA006973-53S2

Regional Oncology Research Center

National Institutes of Health

Grant: 5P50CA097186-13

Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment

National Institutes of Health

Grant: 1U01CA196390-01

Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry

National Institutes of Health

Grant: 1R01CA183965-01

Role of TOP2B in generating complex genomic rearrangements in human cancer

greenLicense: cc-by-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/07/05/2021.07.04.450352.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.07.04.450352

repositoryhttps://doi.org/10.1101/2021.07.04.450352

https://doi.org/10.1002/pros.24210

Fields of Study

Prostate Cancer Treatment and ResearchCancer, Lipids, and MetabolismUbiquitin and proteasome pathways0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

LNCaPEnzalutamideProstate cancerCastrationCell cultureIn vivoBicalutamideCancer researchBiologyIn vitroAndrogenAndrogen receptorCancerEndocrinologyGeneticsHormoneMaleProstatic Neoplasms, Castration-ResistantPhenotypeCell Line, TumorAnimalsHumansandrogen signaling; castration resistance; cell line models; xenograftCell Proliferation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being